Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Belladonna
|
| gptkbp:activities |
blocks acetylcholine receptors
|
| gptkbp:affects |
decreases secretions
|
| gptkbp:clinical_trial |
cardiology
pediatric medicine emergency medicine ophthalmology 100% when administered intravenously |
| gptkbp:contraindication |
gptkb:sneaker
gptkb:Insurance_Company urinary retention prostatic hypertrophy tachyarrhythmias |
| gptkbp:discovered_by |
gptkb:Atropa_belladonna
|
| gptkbp:displacement |
from muscarinic receptors
|
| gptkbp:dissolved |
soluble in alcohol
slightly soluble in water soluble in chloroform |
| https://www.w3.org/2000/01/rdf-schema#label |
Atropine
|
| gptkbp:ingredients |
C17 H23 N O3
|
| gptkbp:is_affected_by |
can cause sedation
|
| gptkbp:is_used_for |
organophosphate poisoning
bradycardia anesthesia adjunct |
| gptkbp:level |
9.7
|
| gptkbp:lifespan |
2 hours
|
| gptkbp:manager |
intravenous
subcutaneous intramuscular |
| gptkbp:mass |
289.37 g/mol
|
| gptkbp:metabolism |
liver
|
| gptkbp:produced_by |
tropacocaine
tropine |
| gptkbp:products |
gptkb:scopolamine
hyoscyamine |
| gptkbp:replaced_by |
1833
|
| gptkbp:rounds |
renal
|
| gptkbp:side_effect |
constipation
dry mouth blurred vision increases heart rate tachycardia urinary retention |
| gptkbp:traded_on |
gptkb:Atro_Pen
gptkb:Atropine_sulfate gptkb:Isopto_Atropine |
| gptkbp:treatment |
cholinergic toxicity
|
| gptkbp:type_of |
51-55-8
|
| gptkbp:visual_effects |
dilates pupils
|